Key Principles and Recommended Regimens for First-line Antiretroviral Therapy
Summary
- Atazanavir + Ritonavir Initial Therapy
- The phase III CASTLE study compared atazanavir + ritonavir vs lopinavir/ritonavir in 883 treatment-naive patients[Molina 2008]
- At the Week 48 primary endpoint analysis, atazanavir + ritonavir was noninferior to lopinavir/ritonavir, with 78% vs 76% achieving HIV-1 RNA < 50 copies/mL
- Noninferiority confirmed at Week 96[Molina 2010]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Initial Antiretroviral Therapy